-24.30 (-1.91%) Dr. Reddy’s Laboratories’ wholly-owned subsidiary -- betapharm Arzneimittel GmbH, Germany has received a communication from the Regulatory Authority of Germany (Regierung von Oberbayern), that the GMP compliance certificate in respect of the company's Formulations Manufacturing Unit 2 plant in Bachupally, Hyderabad is not renewed consequent to the recent inspection of the plant. Pending revocation of the non-compliance notification, the plant will not be able to make any further despatch to the European Union until the next inspection, to be initiated by an invitation from betapharm.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.